Cargando…
A randomized, observer-blinded, equivalence trial comparing two variations of Euvichol®, a bivalent killed whole-cell oral cholera vaccine, in healthy adults and children in the Philippines()
BACKGROUND: To contribute to the global demand for oral cholera vaccine (OCV), the production of Euvichol® was scaled up with elimination of thimerosal. To demonstrate the equivalence of the variations, a study was carried out in the Philippines. METHODS: Healthy male and female adults and children...
Autores principales: | Russo, Paola, Ligsay, Antonio D., Olveda, Remigio, Choi, Seuk Keun, Kim, Deok Ryun, Park, Ju Yeon, Park, Ju Yeong, Syed, Khalid Ali, Dey, Ayan, Kim, Yang Hee, Lee, Sung Hee, Kim, Jayoung, Chon, Yun, Digilio, Laura, Kim, Chan Wha, Excler, Jean-Louis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6026293/ https://www.ncbi.nlm.nih.gov/pubmed/29895500 http://dx.doi.org/10.1016/j.vaccine.2018.05.102 |
Ejemplares similares
-
Immunogenicity of a bivalent killed thimerosal-free oral cholera vaccine, Euvichol, in an animal model
por: Lee, Eun Young, et al.
Publicado: (2018) -
The Euvichol story – Development and licensure of a safe, effective and affordable oral cholera vaccine through global public private partnerships
por: Odevall, Lina, et al.
Publicado: (2018) -
Schistosomiasis in the Philippines: Innovative Control Approach is Needed if Elimination is the Goal
por: Olveda, Remigio M., et al.
Publicado: (2019) -
A community intervention effectiveness study of single dose or two doses of bivalent HPV vaccine (CERVARIX®) in female school students in Thailand
por: Jiamsiri, Suchada, et al.
Publicado: (2022) -
A Randomized, Placebo-Controlled Trial Evaluating Safety and Immunogenicity of the Killed, Bivalent, Whole-Cell Oral Cholera Vaccine in Ethiopia
por: Desai, Sachin N., et al.
Publicado: (2015)